Kinaxis Inc. (TSE:KXS – Get Free Report) Director Gillian (Jill) Denham sold 15,968 shares of Kinaxis stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of C$171.36, for a total transaction of C$2,736,276.48. Following the transaction, the director directly owned 18,732 shares of the company’s stock, valued at approximately C$3,209,915.52. This trade represents a 46.02% decrease in their ownership of the stock.
Kinaxis Stock Performance
TSE KXS traded down C$1.52 during mid-day trading on Wednesday, reaching C$169.22. 65,898 shares of the stock were exchanged, compared to its average volume of 122,506. The business’s 50 day moving average is C$158.22 and its 200-day moving average is C$145.34. Kinaxis Inc. has a 1 year low of C$117.22 and a 1 year high of C$201.00. The company has a market capitalization of C$4.60 billion, a P/E ratio of 55.30, a P/E/G ratio of 3.60 and a beta of 0.76. The company has a debt-to-equity ratio of 11.14, a quick ratio of 2.29 and a current ratio of 1.88.
Kinaxis (TSE:KXS – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported C$1.08 earnings per share for the quarter. The firm had revenue of C$230.64 million during the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%. On average, equities research analysts forecast that Kinaxis Inc. will post 4.2526231 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on KXS
About Kinaxis
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Recommended Stories
- Five stocks we like better than Kinaxis
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
